Skip to main content
Top
Published in: Journal of the International AIDS Society 4/2010

Open Access 01-12-2010 | Oral presentation

0315. The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers

Authors: J Ashby, LJ Garvey, OW Erlwein, H Lamba, R Weston, K Legg, MO McClure, L Dickinson, A D'Avolio, DJ Back, A Winston

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Login to get access

Excerpt

Treatment of chronic hepatitis C virus (HCV) infection in HIV-1 co-infected individuals remains challenging due to numerous factors including drug-drug interactions. The aim of this study was to assess the safety and pharmacokinetic (PK) profile of raltegravir, a recently licensed antiretroviral agent, and ribavirin, when dosed separately and together. …
Metadata
Title
0315. The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers
Authors
J Ashby
LJ Garvey
OW Erlwein
H Lamba
R Weston
K Legg
MO McClure
L Dickinson
A D'Avolio
DJ Back
A Winston
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S4-O33

Other articles of this Special Issue 4/2010

Journal of the International AIDS Society 4/2010 Go to the issue